UBS Sees Eli Lilly Sustaining Obesity Growth
UBS said Eli Lilly's strong results and higher guidance support continued obesity growth.
Related stories
Starbucks Fiscal Q4 Profit Rises 409%
Starbucks reported fiscal fourth-quarter profit up 409%.
M impact | EQUITY | Oct 30, 2026, 05:43 PM UTC
Alphabet Shares Fall After Q3 Earnings Miss, Losing Over $500 Billion
The sell-off followed disappointing advertising revenue, slower Google Search growth and concerns about AI expansion costs. Google Cloud performance was strong, while investors que
M impact | EQUITY | Oct 30, 2026, 05:36 PM UTC
Global Payments Shares Jump 12% on CD&R Interest Report
Global Payments shares rose 12% in afternoon trading after a report of CD&R’s interest in acquiring the payments processor.
M impact | EQUITY | Oct 30, 2026, 05:35 PM UTC
US session market picture: S&P 500 -1.85%, Nasdaq 100 -3.63%; EUR/USD -0.21%, WTI +2.76%, INTC leads volume
US session market picture. US index futures: S and P futures is down 1.85 percent, Nasdaq futures is down 3.63 percent, Dow futures is down 1.03 percent and Russell futures is down
M impact | EQUITY | Oct 30, 2026, 05:30 PM UTC
Walmart Takes Stake in Base Power, Plans Texas Home Energy Offerings
Walmart made a strategic investment in private Base Power and will offer the company’s home energy products.
M impact | EQUITY | Oct 30, 2026, 05:26 PM UTC
Coinbase Shares Fall Nearly 7% After Third-Quarter Results
Coinbase shares fell nearly 7% in premarket trading Friday as investors focused on weaker core revenue and executives’ plans to sell up to $2.2 billion of stock, despite a headline
M impact | EQUITY | Oct 30, 2026, 05:26 PM UTC